Occurrence of satA and vgb Genes in Streptogramin-Resistant Enterococcus faecium Isolates of Animal and Human Origins in The Netherlands
Year: 1998
Type: article
Abstract: Enteroccocci have emerged as an important cause of nosocomial infections. Infections caused by multiresistant enterococci are treated with vancomycin or another glycopeptide. In recent years the usage of vancomycin and the isolation rate of vancomycin-resistant enterococci (VRE) have steadily increased in both Europe and the United States (8). Despite the fact that VRE infections are a hospital problem and the human usage of glycopeptides is in hospitals, VRE have been isolated from the fecal flora of healthy humans without a known hospital connection, from animals, and from the environment (1, 5, 9). One of the few options for treatment of vancomycin-resistantEnterococcus faecium infection is quinopristin-dalfopristin, a mixture (30:70 ratio) of two streptogramins: dalfopristin (streptogramin A) and quinopristin (streptogramin B) (6). A related mixed compound virginiamycin has been used in Europe for many years as a feed additive to enhance growth in food animals. High numbers of virginiamycin-resistant E. faecium have been isolated from the feces of food animals, and these were also resistant to quinopristin-dalfopristin, indicating cross-resistance between virginiamycin and quinopristin-dalfopristin (2, 13, 15).
Authors: Lars Bogø Jensen, Anette M. Hammerum, Frank M. Aarestrup, Anthony E. van den Bogaard, Ellen E. Stobberingh
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2065955348
